Neuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson’s Disease

It is now well recognized that a bidirectional relationship between gut microbiota and the brain, referred to as the gut-brain axis, plays a prominent role in maintaining homeostasis and that a disruption in this axis can result in neuroinflammatory response and neurological disorders such as Parkinson’s disease (PD). The protective action of probiotics such as Bifidobacterium animalis ssp . lactis Bb12 and Lactobacillus rhamnosus GG in various animal models of PD has been reported. Therefore, in this study, we used an inflammatory model of PD to assess the effects of a combination of these two probiotics (Microbiot ® ) on motor behavior as well as on the response of microglia, including microglia morphology, to gain a better understanding of their mechanism of action. Microbiot ® (300 µL) was administered orally once daily for 15 days in a lipopolysaccharide-induced PD model using male Wistar rats. Although LPS-induced motor asymmetry in cylinder test was not affected by Microbiot ® , impairment of motor coordination in the narrow-beam test was significantly reduced by this probiotic. Moreover, Microbiot ® treatment reduced microglial activation suggesting an anti-inflammatory effect. While further mechanistic investigation of Microbiot ® in neurodegenerative diseases is warranted, our results support the potential utility of probiotics in PD.